Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinones

被引：48

作者：

Colletti, SL ^{[1
]}

Frie, JL ^{[1
]}

Dixon, EC ^{[1
]}

Singh, SB ^{[1
]}

Choi, BK ^{[1
]}

Scapin, G ^{[1
]}

Fitzgerald, CE ^{[1
]}

Kumar, S ^{[1
]}

Nichols, EA ^{[1
]}

O'Keefe, SJ ^{[1
]}

O'Neill, EA ^{[1
]}

Porter, G ^{[1
]}

Samuel, K ^{[1
]}

Schmatz, DM ^{[1
]}

Schwartz, CD ^{[1
]}

Shoop, WL ^{[1
]}

Thompson, CM ^{[1
]}

Thompson, JE ^{[1
]}

Wang, RX ^{[1
]}

Woods, A ^{[1
]}

Zaller, DM ^{[1
]}

Doherty, JB ^{[1
]}

机构：

[1] Merck & Co Inc, Merck Res Labs, Rahway, NJ 07065 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2003年 / 46卷 / 03期

关键词：

D O I：

10.1021/jm025585h

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Imidazo[1,2-alpha]pyridyl N-arylpyridazinones were hybridized from the classic pyridinylimidazoles and the more recent dual hydrogen bond acceptors, resulting in a new structural class of selective p38 MAP kinase inhibitors.

引用

页码：349 / 352

页数：4

共 24 条

[1] [Anonymous], [No title captured], Patent No. 9964400
[2] Bemis GW., 1998, patent, Patent No. [WO9827098, 9827098]
[3] New inhibitors of p38 kinase
Boehm, JC
Adams, JL
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (01) : 25 - 37
[4] Bondeson J, 2001, INT J CLIN PRACT, V55, P211
[5] MAP kinases
Chen, Z
Gibson, TB
Robinson, F
Silvestro, L
Pearson, G
Xu, BE
Wright, A
Vanderbilt, C
Cobb, MH
[J]. CHEMICAL REVIEWS, 2001, 101 (08) : 2449 - 2476
[6] CLAIBORN CF, 2001, Patent No. 0122965
[7] Regulation of stress-induced cytokine production by pyridinylimidazoles; Inhibition of CSBP kinase
Gallagher, TF
Seibel, GL
Kassis, S
Laydon, JT
Blumenthal, MJ
Lee, JC
Lee, D
Boehm, JC
FierThompson, SM
Abt, JW
Soreson, ME
Smietana, JM
Hall, RF
Garigipati, RS
Bender, PE
Erhard, KF
Krog, AJ
Hofmann, GA
Sheldrake, PL
McDonnell, PC
Kumar, S
Young, PR
Adams, JL
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (01) : 49 - 64
[8] GILCHRIST TL, 1997, HETEROCYCLIC CHEM, P298
[9] Effect of pimobendan on exercise capacity in patients with heart failure: Main results from the Pimobendan in Congestive Heart Failure (PICO) trial
Heyndrickx, G
Renard, M
Beil, S
Doering, W
Kauder, E
Klepzig, H
Schacherer, C
Haass, M
Kruger, C
Limbourg, P
Liomin, E
Maisch, B
Schartl, M
Simon, H
Bernink, PJLM
Fels, PW
Dohmen, HJM
Dunselman, PHJM
Baselier, MRP
Holwerda, NJ
Laarman, GJ
Leenders, CM
vanLeeuwen, K
Michels, HR
vanderEnt, M
Remme, WJ
Withagen, AJAM
Gundersen, T
Otterstad, JE
Froland, G
Pedersen, TR
Ferreira, JRG
deSa, EP
SeabraGomes, R
Gil, V
Abdon, NJ
Jonsson, J
Lubsen, J
[J]. HEART, 1996, 76 (03) : 223 - 231
[10] Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38 delta
Jiang, Y
Gram, H
Zhao, M
New, LG
Gu, J
Feng, LL
DiPadova, F
Ulevitch, RJ
Han, JH
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) : 30122 - 30128

← 1 2 3 →